Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28659) 28659
Book Review (463) 463
Publication (311) 311
Newspaper Article (174) 174
Book / eBook (33) 33
Book Chapter (21) 21
Report (9) 9
Magazine Article (7) 7
Dissertation (4) 4
Web Resource (3) 3
Conference Proceeding (2) 2
Government Document (2) 2
Paper (2) 2
Trade Publication Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
medicine & public health (26637) 26637
health economics (26572) 26572
pharmacoeconomics and health outcomes (26498) 26498
quality of life research (25830) 25830
public health (6925) 6925
health administration (3541) 3541
humans (3119) 3119
pharmacoeconomics (2829) 2829
pharmacology & pharmacy (2510) 2510
health policy & services (2200) 2200
health care sciences & services (2183) 2183
economics (1970) 1970
index medicus (1637) 1637
studies (1509) 1509
female (1212) 1212
cost analysis (1133) 1133
male (1125) 1125
cost-benefit analysis (1103) 1103
analysis (1023) 1023
middle aged (929) 929
health technology assessment (868) 868
adult (848) 848
research (847) 847
quality of life (826) 826
cost-effectiveness (773) 773
patients (760) 760
health (744) 744
aged (716) 716
economic aspects (682) 682
care and treatment (623) 623
medical care, cost of (592) 592
quality-of-life (585) 585
health care management (570) 570
health behavior (555) 555
decision making (510) 510
cost effectiveness (508) 508
usage (507) 507
medicine (450) 450
health policy (449) 449
europe (443) 443
health care (430) 430
drugs (422) 422
analysis of health care markets (420) 420
disease (420) 420
care (418) 418
health care expenditures (412) 412
management (411) 411
economic policy (409) 409
mortality (405) 405
drug therapy (399) 399
quality-adjusted life years (383) 383
health care costs (380) 380
models, economic (380) 380
treatment outcome (378) 378
cancer (371) 371
costs (369) 369
health aspects (368) 368
pharmacy (368) 368
economics, pharmaceutical (359) 359
health care policy (339) 339
clinical trials (336) 336
adolescent (330) 330
public finance (327) 327
united states (316) 316
impact (315) 315
therapy (314) 314
economic theory (312) 312
cost of illness (311) 311
cost-effectiveness analysis (305) 305
hospitals (303) 303
economic models (300) 300
systematic review (299) 299
pharmaceutical industry (281) 281
original (280) 280
decision-making (278) 278
economic-evaluation (274) 274
prevention (272) 272
population (269) 269
quality (266) 266
medical research (264) 264
pharmacology (262) 262
drug costs (261) 261
united-states (260) 260
aged, 80 and over (256) 256
public finance & economics (255) 255
pharmaceuticals (254) 254
methods (250) 250
surveys and questionnaires (246) 246
outcomes (245) 245
efficacy (233) 233
cost control (225) 225
children (223) 223
chemotherapy (222) 222
diagnosis (222) 222
preferences (220) 220
original research article (219) 219
united kingdom (218) 218
medical care (217) 217
health-care (215) 215
markov chains (213) 213
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28886) 28886
German (12) 12
Spanish (11) 11
Japanese (8) 8
Turkish (2) 2
Croatian (1) 1
Czech (1) 1
French (1) 1
Korean (1) 1
Polish (1) 1
Russian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Validation of the Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM)
by Willis, Michael and Johansen, Pierre and Nilsson, Andreas and Asseburg, Christian
PharmacoEconomics, ISSN 1170-7690, 3/2017, Volume 35, Issue 3, pp. 375 - 396
The Economic and Health Outcomes Model of Type 2 Diabetes Mellitus (ECHO-T2DM) was developed to address study questions pertaining to the cost-effectiveness of... 
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | COST-EFFECTIVENESS | GLYCEMIC CONTROL | GLUCOSE CONTROL | FOLLOW-UP | RISK | SIMULATION-MODEL | TASK-FORCE | HEALTH CARE SCIENCES & SERVICES | CARDIOVASCULAR-DISEASE | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | COMPLICATIONS | ECONOMICS | HOOD CHALLENGE | Type 2 diabetes | Economic aspects | Clinical trials | Usage | Patient outcomes | Consortia | Studies | Validity | Accuracy | Hyperglycemia | Simulation | Decision making | Mortality | Pharmacoeconomics | Diabetes | Cost analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Parent Preferences for Health Outcomes Associated with Autism Spectrum Disorders
by Lavelle, Tara A and Weinstein, Milton C and Newhouse, Joseph P and Munir, Kerim and Kuhlthau, Karen A and Prosser, Lisa A
PharmacoEconomics, ISSN 1170-7690, 4/2019, Volume 37, Issue 4, pp. 541 - 551
Few studies have used preference-based quality-of-life outcomes to assess how autism spectrum disorders (ASDs) affect children and parents, and none have... 
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | COST-EFFECTIVENESS | QALYS | STATES | US VALUATION | TIME TRADE-OFF | CHILDREN | FAMILY | ECONOMIC-EVALUATION | HEALTH CARE SCIENCES & SERVICES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | ECONOMICS | QUALITY-OF-LIFE | UTILITY | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text The association of potentially inappropriate medication use on health outcomes and hospital costs in community-dwelling older persons: a longitudinal 12-year study
by Hyttinen, Virva and Jyrkkä, Johanna and Saastamoinen, Leena K and Vartiainen, Anna-Kaisa and Valtonen, Hannu
The European Journal of Health Economics, ISSN 1618-7598, 3/2019, Volume 20, Issue 2, pp. 233 - 243
To determine (1) whether potentially inappropriate medication (PIM) use defined by the Meds75 + database is associated with fracture-specific hospitalisations... 
Health Economics | Economic Policy | Public Health | Health outcomes | Hospital costs | Public Finance | Health Care Management | Older persons | Potentially inappropriate medications | J14 Economics of the Elderly | Register-based study | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | MORTALITY | REGISTER | BEERS CRITERIA | DRUG-USE | CARE OUTCOMES | HEALTH POLICY & SERVICES | PEOPLE | COHORT | ECONOMICS | AGE | Drugs | Usage | Prescription writing | Analysis | Mortality | Health care industry | Aged | Health aspects | Medical care, Cost of | Studies | Fractures | Medical errors | Older people | Clinical outcomes | Drug use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review
by Hua, Xinyang and Lung, Thomas Wai-Chun and Palmer, Andrew and Si, Lei and Herman, William H and Clarke, Philip
PharmacoEconomics, ISSN 1170-7690, 3/2017, Volume 35, Issue 3, pp. 319 - 329
There are an increasing number of studies using simulation models to conduct cost-effectiveness analyses for type 2 diabetes mellitus.To evaluate the... 
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | COST-EFFECTIVENESS ANALYSIS | UNITED-STATES | UTILITY ANALYSIS | THERAPY CONVERSION | LONG-TERM OUTCOMES | BLOOD-GLUCOSE | BIPHASIC INSULIN ASPART | NPH INSULIN | HUMAN PREMIX INSULIN | HEALTH CARE SCIENCES & SERVICES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | ECONOMICS | ACTING BASAL INSULIN | Quality-Adjusted Life Years | Hypoglycemic Agents - economics | Glycated Hemoglobin A - metabolism | Humans | Risk Factors | Diabetes Mellitus, Type 2 - economics | Linear Models | Models, Economic | Blood Glucose - drug effects | Hypoglycemic Agents - administration & dosage | Computer Simulation | Cost-Benefit Analysis | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Care and treatment | Usage | Patient outcomes | Analysis | Glycosylated hemoglobin | Risk factors | Quality of life | Studies | Intervention | Life expectancy | Simulation | Diabetes | Cost analysis | Insulin | Systematic Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure
: A Systematic Review
by Goehler, Alexander and Geisler, Benjamin P and Manne, Jennifer M and Jahn, Beate and Conrads-Frank, Annette and Gazelle, G Scott and Siebert, Uwe
PharmacoEconomics, ISSN 1170-7690, 9/2011, Volume 29, Issue 9, pp. 753 - 769
Chronic heart failure (CHF) is a critical public health issue with increasing effect on the healthcare budgets of developed countries. Various decisionanalytic... 
Quality of Life Research | Health Economics | Health Administration | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | Heart-failure | Cost-effectiveness | Modelling | MYOCARDIAL-INFARCTION | DISEASE MANAGEMENT | NATRIURETIC PEPTIDE | ASSIST DEVICES | BETA-BLOCKER THERAPY | ECONOMIC-EVALUATION | CARDIAC RESYNCHRONIZATION THERAPY | IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR | LEFT-VENTRICULAR DYSFUNCTION | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | ECONOMICS | MANAGEMENT PROGRAMS | Cost-effectiveness; Heart-failure; Modelling. | Heart failure | Care and treatment | Economic aspects | Research | Diagnosis | Medical care, Cost of | Cardiovascular agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Symptoms and Concerns Among Children and Young People with Life-Limiting and Life-Threatening Conditions: A Systematic Review Highlighting Meaningful Health Outcomes
by Namisango, Eve and Bristowe, Katherine and Allsop, Matthew J and Murtagh, Fliss E. M and Abas, Melanie and Higginson, Irene J and Downing, Julia and Harding, Richard
The Patient - Patient-Centered Outcomes Research, ISSN 1178-1653, 2/2019, Volume 12, Issue 1, pp. 15 - 55
The design and provision of quality pediatric palliative care should prioritize issues that matter to children and their families for optimal outcomes.This... 
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | EXPERIENCES | CANCER-RELATED SYMPTOMS | PERSPECTIVE | ADOLESCENTS | PEDIATRIC PALLIATIVE CARE | HEALTH CARE SCIENCES & SERVICES | PARENTS | HEALTH POLICY & SERVICES | END | QUALITY-OF-LIFE | ILL CHILDREN | BRAIN-TUMORS | Palliative Care | Anxiety | Terminally Ill - psychology | Child | Humans | Adolescent
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text More improvements needed in health outcomes in UK
PharmacoEconomics & Outcomes News, ISSN 1173-5503, 7/2018, Volume 808, Issue 1, pp. 3 - 3
Quality of Life Research | Health Economics | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Applying comparative effectiveness data to medical decision making
: a practical guide
by Asche, Carl V., editor
2016, ISBN 3319220640, viii, 113 pages
"This textbook introduces students to the basic concepts and methods used to measure and compare the expected benefits, risks and cost of preventive and... 
Medicine | Medical care | Effectiveness | Decision making | Health Services Research | Medicine & Public Health | Pharmacoeconomics and Health Outcomes
Book
Details down arrow
9. Full Text CAUTI prevention reduces cost and improves health outcomes
PharmacoEconomics & Outcomes News, ISSN 1173-5503, 3/2018, Volume 799, Issue 1, pp. 10 - 10
Quality of Life Research | Health Economics | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Discrete Choice Experiments in Health Economics: A Review of the Literature
by Clark, Michael D and Determann, Domino and Petrou, Stavros and Moro, Domenico and de Bekker-Grob, Esther W
PharmacoEconomics, ISSN 1170-7690, 9/2014, Volume 32, Issue 9, pp. 883 - 902
Discrete choice experiments (DCEs) are increasingly used in health economics to address a wide range of health policy-related concerns.Broadly adopting the... 
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | STATED PREFERENCE | TREATMENT OUTCOMES | PARENT PREFERENCES | ADAPTIVE CONJOINT-ANALYSIS | MULTICRITERIA DECISION-ANALYSIS | WILLINGNESS-TO-PAY | COLORECTAL-CANCER | BASAL-CELL CARCINOMA | HEALTH CARE SCIENCES & SERVICES | WOMENS PREFERENCES | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | ECONOMICS | UNDERSTANDING PATIENT PREFERENCES | Medical policy | Evaluation | Usage | Medical innovations | Medical economics | Analysis | Studies | Health economics | Discrete element method | Econometrics | Health care policy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text The Epidemiology of Obesity: A Big Picture
by Hruby, Adela and Hu, Frank B
PharmacoEconomics, ISSN 1170-7690, 7/2015, Volume 33, Issue 7, pp. 673 - 689
The epidemic of overweight and obesity presents a major challenge to chronic disease prevention and health across the life course around the world. Fueled by... 
Quality of Life Research | Health Economics | Health Administration | Public Health | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | UNITED-STATES | SHORT-SLEEP DURATION | LIFE-STYLE | HEALTH CARE SCIENCES & SERVICES | BODY-MASS INDEX | PHARMACOLOGY & PHARMACY | HEALTH POLICY & SERVICES | SUGAR-SWEETENED BEVERAGES | PHYSICAL-ACTIVITY | WEIGHT-GAIN | ECONOMICS | BUILT ENVIRONMENT | CORONARY-HEART-DISEASE | TYPE-2 DIABETES-MELLITUS | Prevalence | Age Factors | Nutrition Surveys | Humans | Obesity - epidemiology | Risk Factors | Cost of Illness | Feeding Behavior | Obesity - etiology | Obesity - economics | Socioeconomic Factors | Obesity | Epidemiology | Patient outcomes | Analysis | Risk factors | Studies | Trends | International
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text The impact of CT colonography for colorectal cancer screening on the UK NHS
: Costs, healthcare resources and health outcomes
by Sweet, Alison and Lee, David and Gairy, Kerry and Phiri, Denver and Reason, Timothy and Lock, Kevin
Applied Health Economics and Health Policy, ISSN 1175-5652, 1/2011, Volume 9, Issue 1, pp. 51 - 64
Biennial faecal occult blood testing (FOBT) for individuals aged 60–69 years is the primary screening tool for colorectal cancer (CRC) in the UK NHS, despite a... 
Quality of Life Research | Health Economics | Health Administration | Pharmacoeconomics and Health Outcomes | Medicine & Public Health | Screening | Budget-impact-analysis | Computed-tomography | Colorectal-cancer, diagnosis | Colorectal-cancer, prevention | Cost-Benefit Analysis - economics | Models, Econometric | Colonography, Computed Tomographic - economics | Age Factors | Mass Screening - economics | Humans | Middle Aged | Colorectal Neoplasms - prevention & control | Mass Screening - statistics & numerical data | United Kingdom | Colorectal Neoplasms - diagnosis | Colorectal Neoplasms - economics | Colorectal Neoplasms - therapy | Outcome and Process Assessment (Health Care) | Colonography, Computed Tomographic - statistics & numerical data | Aged | Occult Blood | Budget-impact-analysis; Colorectal-cancer; diagnosis; Colorectal-cancer; prevention; Computed-tomography; Screening. | Usage | Colonoscopy | Analysis | Colorectal cancer | Economic aspects | Diagnosis | Research | Medical care, Cost of | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights